Resultats de la cerca - Horak, Peter
- Mostrar 1 - 20 resultats de 33
- Anar a la pàgina següent
-
1
-
2
-
3
-
4
-
5
-
6
-
7
Circulating Endothelial Progenitor Cells in Castration Resistant Prostate Cancer: A Randomized, Controlled, Biomarker Study per Fuereder, Thorsten, Wacheck, Volker, Strommer, Sabine, Horak, Peter, Gerschpacher, Marion, Lamm, Wolfgang, Kivaranovic, Danijel, Krainer, Michael
Publicat 2014Text -
8
MALAT1 Fusions and Basal Cells Contribute to Primary Resistance against Androgen Receptor Inhibition in TRAMP Mice per Marhold, Maximilian, Udovica, Simon, Topakian, Thais, Horak, Peter, Horvat, Reinhard, Tomasich, Erwin, Heller, Gerwin, Krainer, Michael
Publicat 2022Text -
9
Synthetic lethal combinations of low-toxicity drugs for breast cancer identified in silico by genetic screens in yeast per Marhold, Maximilian, Tomasich, Erwin, Schwarz, Michael, Udovica, Simon, Heinzel, Andreas, Mayer, Paul, Horak, Peter, Perco, Paul, Krainer, Michael
Publicat 2018Text -
10
PD-1 and PD-L1 expression on TILs in peritoneal metastases compared to ovarian tumor tissues and its associations with clinical outcome per Bekos, Christine, Pils, Dietmar, Dekan, Sabine, Hofstetter, Gerda, Horak, Peter, Reinthaller, Alexander, Polterauer, Stephan, Schwameis, Richard, Aust, Stefanie
Publicat 2021Text -
11
Patient expectations are better for immunotherapy than traditional chemotherapy for cancer per Ihrig, Andreas, Richter, Jenniffer, Grüllich, Carsten, Apostolidis, Leonidas, Horak, Peter, Villalobos, Matthias, Grapp, Miriam, Friederich, Hans-Christoph, Maatouk, Imad
Publicat 2020Text -
12
Negative feedback control of HIF-1 through REDD1-regulated ROS suppresses tumorigenesis per Horak, Peter, Crawford, Andrew R., Vadysirisack, Douangsone D., Nash, Zachary M., DeYoung, M. Phillip, Sgroi, Dennis, Ellisen, Leif W.
Publicat 2010Text -
13
FCM(PASS) Software Aids Extracellular Vesicle Light Scatter Standardisation per Welsh, Joshua A., Horak, Peter, Wilkinson, James S., Ford, Verity J, Jones, Jennifer C., Smith, David, Holloway, Judith A., Englyst, Nicola A.
Publicat 2019Text -
14
The prognostic value of estrogen receptor beta and proline-, glutamic acid- and leucine-rich protein 1 (PELP1) expression in ovarian cancer per Aust, Stefanie, Horak, Peter, Pils, Dietmar, Pils, Sophie, Grimm, Christoph, Horvat, Reinhard, Tong, Dan, Schmid, Bernd, Speiser, Paul, Reinthaller, Alexander, Polterauer, Stephan
Publicat 2013Text -
15
Deconvolution of sarcoma methylomes reveals varying degrees of immune cell infiltrates with association to genomic aberrations per Simon, Malte, Mughal, Sadaf S., Horak, Peter, Uhrig, Sebastian, Buchloh, Jonas, Aybey, Bogac, Stenzinger, Albrecht, Glimm, Hanno, Fröhling, Stefan, Brors, Benedikt, Imbusch, Charles D.
Publicat 2021Text -
16
Correction to: Deconvolution of sarcoma methylomes reveals varying degrees of immune cell infiltrates with association to genomic aberrations per Simon, Malte, Mughal, Sadaf S., Horak, Peter, Uhrig, Sebastian, Buchloh, Jonas, Aybey, Bogac, Stenzinger, Albrecht, Glimm, Hanno, Fröhling, Stefan, Brors, Benedikt, Imbusch, Charles D.
Publicat 2022Text -
17
TUSC3 Loss Alters the ER Stress Response and Accelerates Prostate Cancer Growth in vivo per Horak, Peter, Tomasich, Erwin, Vaňhara, Petr, Kratochvílová, Kateřina, Anees, Mariam, Marhold, Maximilian, Lemberger, Christof E., Gerschpacher, Marion, Horvat, Reinhard, Sibilia, Maria, Pils, Dietmar, Krainer, Michael
Publicat 2014Text -
18
Community-driven development of a modified progression-free survival ratio for precision oncology per Mock, Andreas, Heilig, Christoph E, Kreutzfeldt, Simon, Huebschmann, Daniel, Heining, Christoph, Schröck, Evelin, Brors, Benedikt, Stenzinger, Albrecht, Jäger, Dirk, Schlenk, Richard, Glimm, Hanno, Fröhling, Stefan, Horak, Peter
Publicat 2019Text -
19
A nanoporous gold membrane for sensing applications per Oo, Swe Zin, Silva, Gloria, Carpignano, Francesca, Noual, Adnane, Pechstedt, Katrin, Mateos, Luis, Grant-Jacob, James A., Brocklesby, Bill, Horak, Peter, Charlton, Martin, Boden, Stuart A., Melvin, Tracy
Publicat 2016Text -
20
Ruxolitinib is effective in the treatment of a patient with refractory T‐ALL per Jaramillo, Sonia, Hennemann, Hannah, Horak, Peter, Teleanu, Veronica, Heilig, Christoph E., Hutter, Barbara, Stenzinger, Albrecht, Glimm, Hanno, Goeppert, Benjamin, Müller‐Tidow, Carsten, Fröhling, Stefan, Schönland, Stefan, Schlenk, Richard F.
Publicat 2020Text